{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:57:36Z","timestamp":1790690256054,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes on Drug Abuse (NIDA)","award":["DA022694"],"award-info":[{"award-number":["DA022694"]}]},{"name":"National Institutes on Drug Abuse (NIDA)","award":["DA15378"],"award-info":[{"award-number":["DA15378"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.pbb.2013.09.012","type":"journal-article","created":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T09:17:27Z","timestamp":1380446247000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model"],"prefix":"10.1016","volume":"112","author":[{"given":"Robert B.","family":"Raffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet S.","family":"Bhandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.09.012_bb0005","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/S0028-3908(00)00157-X","article-title":"The opioid antagonist naltrexone inhibits activity and alters expression of \u03b17 and \u03b14\u03b22 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs","volume":"39","author":"Almeida","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0010","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1460-9568.2004.03714.x","article-title":"Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice","volume":"20","author":"Balerio","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0015","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1523\/JNEUROSCI.22-24-10935.2002","article-title":"Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice","volume":"22","author":"Berrendero","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1523\/JNEUROSCI.3008-04.2005","article-title":"Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene","volume":"25","author":"Berrendero","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neubiorev.2010.02.006","article-title":"Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system","volume":"35","author":"Berrendero","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2013.09.012_bb0030","first-page":"755","article-title":"Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice","volume":"57","author":"Biala","year":"2005","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2013.09.012_bb0035","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1523\/JNEUROSCI.4275-07.2008","article-title":"Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens","volume":"28","author":"Britt","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1300\/J069v24n02_05","article-title":"Naltrexone augments the effects of nicotine replacement therapy in female smokers","volume":"24","author":"Byars","year":"2005","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pbb.2013.09.012_bb0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000117512","article-title":"Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations","volume":"1","author":"Carolei","year":"1975","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2007.10.026","article-title":"Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms","volume":"430","author":"Chae","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2013.09.012_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1996.tb15232.x","article-title":"Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release","volume":"117","author":"Clarke","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0024-3205(81)90755-4","article-title":"Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat","volume":"28","author":"Conte-Devolx","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02244173","article-title":"Opiate antagonists reduce cocaine but not nicotine self-administration","volume":"104","author":"Corrigall","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1300\/J069v18n01_04","article-title":"Naltrexone effects on short-term and long-term smoking cessation","volume":"18","author":"Covey","year":"1999","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pbb.2013.09.012_bb0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tips.2005.06.002","article-title":"Cannabinoid CB1 receptors control conditioned drug seeking","volume":"26","author":"De Vries","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0024-3205(94)00488-E","article-title":"Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics","volume":"56","author":"Decker","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00213-005-0054-z","article-title":"Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone","volume":"184","author":"DeNoble","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0090","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1046\/j.1471-4159.1995.64041878.x","article-title":"Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine","volume":"64","author":"Dhatt","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2013.09.012_bb0095","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di Matteo","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pbb.2003.09.017","article-title":"Naltrexone attenuates acute cigarette smoking behavior","volume":"77","author":"Epstein","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.09.012_bb0105","first-page":"458","article-title":"Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-d-aspartate receptors in the ventral tegmental area","volume":"294","author":"Fu","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.09.012_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1017\/S1461145708009450","article-title":"Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice","volume":"12","author":"Galeote","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2005.11.034","article-title":"Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal","volume":"530","author":"Goktalay","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0899-3289(88)80018-X","article-title":"Effect of naloxone on cigarette smoking","volume":"1","author":"Gorelick","year":"1988","journal-title":"J Subst Abuse"},{"key":"10.1016\/j.pbb.2013.09.012_bb0125","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.neuropharm.2010.11.010","article-title":"Nicotine and endogenous opioids: neurochemical and pharmacological evidence","volume":"60","author":"Hadjiconstantinou","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0130","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/S0028-3908(00)00119-2","article-title":"Kappa-opioid receptor modulation of nicotine-induced behaviour","volume":"39","author":"Hahn","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(95)00815-2","article-title":"Differential role of \u03b4-opioid receptors in the development and expression of behavioral sensitization to cocaine","volume":"298","author":"Heidbreder","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0006-8993(87)90809-2","article-title":"Plasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig","volume":"406","author":"Hexum","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.09.012_bb0145","doi-asserted-by":"crossref","first-page":"19480","DOI":"10.1073\/pnas.0808023105","article-title":"Insular hypocretin transmission regulates nicotine reward","volume":"105","author":"Hollander","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2013.09.012_bb0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002130050872","article-title":"Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results","volume":"142","author":"Hutchison","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s002130000482","article-title":"Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats","volume":"151","author":"Ise","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00213-010-1845-4","article-title":"Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats","volume":"210","author":"Ismayilova","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00213-008-1315-4","article-title":"Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum","volume":"201","author":"Isola","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0170","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0024-3205(80)90562-7","article-title":"Naloxone reduces cigarette smoking","volume":"27","author":"Karras","year":"1980","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0091-3057(01)00651-7","article-title":"Neurobiology of the nicotine withdrawal syndrome","volume":"70","author":"Kenny","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.09.012_bb0185","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0091-3057(00)00258-6","article-title":"Naltrexone alteration of acute smoking response in nicotine-dependent subjects","volume":"66","author":"King","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.09.012_bb0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/14622200600789767","article-title":"Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences","volume":"8","author":"King","year":"2006","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pbb.2013.09.012_bb0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archpsyc.56.7.663","article-title":"Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence","volume":"56","author":"Krishnan-Sarin","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.012_bb0190","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/14622200310001614601","article-title":"Naltrexone and nicotine patch smoking cessation: a preliminary study","volume":"5","author":"Krishnan-Sarin","year":"2003","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pbb.2013.09.012_bb0200","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/00023210-200822090-00001","article-title":"Role of the glutamatergic system in nicotine dependence: implications for the discovery and development of new pharmacological smoking cessation therapies","volume":"22","author":"Liechti","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2013.09.012_bb0205","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pnpbp.2010.10.007","article-title":"Activation of the opioid mu1, but not delta or kappa, receptors is required for nicotine reinforcement in a rat model of drug self-administration","volume":"35","author":"Liu","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.09.012_bb0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-008-1335-0","article-title":"Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats","volume":"202","author":"Liu","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0215","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00001756-199903170-00006","article-title":"(+\/\u2212)Cyclazocine blocks the dopamine response to nicotine","volume":"10","author":"Maisonneuve","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2013.09.012_bb0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0225","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0091-3057(01)00699-2","article-title":"Nicotine dependence: studies with a laboratory model","volume":"70","author":"Malin","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.09.012_bb0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02244930","article-title":"Naloxone precipitates nicotine abstinence syndrome in the rat","volume":"112","author":"Malin","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0235","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00213-005-0135-z","article-title":"Bupropion attenuates nicotine abstinence syndrome in the rat","volume":"184","author":"Malin","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0091-3057(85)90397-1","article-title":"Effects of nicotine on beta-endorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro","volume":"22","author":"Marty","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.09.012_bb0245","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1126\/science.7569895","article-title":"Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors","volume":"269","author":"McGehee","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pbb.2013.09.012_bb0250","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00174355","article-title":"Naloxone does not affect cigarette smoking","volume":"89","author":"Nemeth-Coslett","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2009.05.022","article-title":"A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms","volume":"615","author":"Pag\u00e1n","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neuroscience.2013.05.010","article-title":"Planarians require an intact brain to behaviorally react to cocaine, but not to react to nicotine","volume":"246","author":"Pagan","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2013.09.012_bb0270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/FBP.0b013e32830c367c","article-title":"Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood","volume":"19","author":"Perkins","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0275","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1074\/mcp.M112.024828","article-title":"Chronic nicotine treatment impacts the regulation of opioid and non-opioid peptides in the rat dorsal striatum","volume":"12","author":"Petruzziello","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.pbb.2013.09.012_bb0280","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0196-9781(87)90133-1","article-title":"Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin","volume":"8","author":"Pierzchala","year":"1987","journal-title":"Peptides"},{"key":"10.1016\/j.pbb.2013.09.012_bb0285","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0306-4530(97)00074-7","article-title":"Endogenous opioids and smoking: a review of progress and problems","volume":"23","author":"Pomerleau","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/382255a0","article-title":"Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs","volume":"382","author":"Pontieri","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2013.09.012_bb0295","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2004.10.052","article-title":"Description and quantification of cocaine withdrawal signs in Planaria","volume":"1032","author":"Raffa","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.09.012_bb0440","series-title":"Planaria: a model for drug action and abuse","author":"Raffa","year":"2008"},{"key":"10.1016\/j.pbb.2013.09.012_bb0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(01)01358-9","article-title":"Cocaine withdrawal in Planaria","volume":"430","author":"Raffa","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0300","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1056-8719(01)00152-6","article-title":"Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint","volume":"45","author":"Raffa","year":"2001","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.pbb.2013.09.012_bb0310","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(03)00814-0","article-title":"Kappa-opioid withdrawal in Planaria","volume":"349","author":"Raffa","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2013.09.012_bb0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2012.01.019","article-title":"Mephedrone (\u201cbath salt\u201d) pharmacology: insights from invertebrates","volume":"208","author":"Ramoz","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2013.09.012_bb0325","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pbb.2007.01.010","article-title":"An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2)","volume":"86","author":"Rawls","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.09.012_bb0335","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pbb.2009.05.005","article-title":"Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians","volume":"93","author":"Rawls","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.09.012_bb0330","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2011.04.001","article-title":"Nicotine behavioral pharmacology: clues from planarians","volume":"118","author":"Rawls","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2013.09.012_bb0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-006-0504-2","article-title":"Association of OPRM1 A118G variant with the relative reinforcing value of nicotine","volume":"188","author":"Ray","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0340","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00213-007-0794-z","article-title":"Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study","volume":"193","author":"Ray","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/1064-1297.15.1.81","article-title":"High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking","volume":"15","author":"Rohsenow","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00213-004-2136-8","article-title":"Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm","volume":"180","author":"Rukstalis","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0360","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2174\/187152708786927859","article-title":"The endocannabinoid system: a new molecular target for the treatment of tobacco addiction","volume":"7","author":"Scherma","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pbb.2013.09.012_bb0365","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.npp.1301238","article-title":"Smoking modulation of \u03bc-opioid and dopamine D2 receptor-mediated neurotransmission in humans","volume":"32","author":"Scott","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0370","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1523\/JNEUROSCI.2980-11.2012","article-title":"Stress-induced activation of the dynorphin\/\u03ba-opioid receptor system in the amygdala potentiates nicotine conditioned place preference","volume":"32","author":"Smith","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0375","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF02245813","article-title":"Naltrexone, smoking behaviour and cigarette withdrawal","volume":"120","author":"Sutherland","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0380","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1460-9568.1998.00135.x","article-title":"A dopamine-\u03bc1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse","volume":"10","author":"Tanda","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2013.09.012_bb0385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0006-8993(01)02388-5","article-title":"Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells","volume":"903","author":"Tom\u00e9","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.09.012_bb0390","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2009.03.013","article-title":"Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin","volume":"56","author":"Trigo","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0395","first-page":"105","article-title":"Naloxone enhances cAMP levels in Planaria","volume":"69C","author":"Venturini","year":"1981","journal-title":"Comp Biochem Physiol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0400","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0742-8413(83)90141-X","article-title":"Radioimmunological and immunocytochemical demonstration of Met-enkephalin in Planaria","volume":"74","author":"Venturini","year":"1983","journal-title":"Comp Biochem Physiol C"},{"key":"10.1016\/j.pbb.2013.09.012_bb0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1300\/J069v27n01_07","article-title":"The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation","volume":"27","author":"Walsh","year":"2008","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pbb.2013.09.012_bb0410","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002130050756","article-title":"Naltrexone administration affects ad libitum smoking behavior","volume":"140","author":"Wewers","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2013.09.012_bb0415","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bst0210429","article-title":"Hippocampal nicotinic autoreceptors modulate acetylcholine release","volume":"21","author":"Wilkie","year":"1993","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pbb.2013.09.012_bb0420","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1360-0443.1999.948122713.x","article-title":"A randomized trial of naltrexone for smoking cessation","volume":"94","author":"Wong","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2013.09.012_bb0425","first-page":"482","article-title":"Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons","volume":"276","author":"Yang","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.09.012_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(95)00761-X","article-title":"Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice","volume":"298","author":"Zarrindast","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.09.012_bb0435","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1744-9081-2-28","article-title":"The mu-opioid receptor gene and smoking initiation and nicotine dependence","volume":"2","author":"Zhang","year":"2006","journal-title":"Behav Brain Funct"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713002281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713002281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T20:54:15Z","timestamp":1564174455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713002281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":87,"alternative-id":["S0091305713002281"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.09.012","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}